Medicine & Life Sciences
Hepatocellular Carcinoma
100%
Liver
82%
Hepacivirus
78%
Liver Transplantation
76%
Fibrosis
70%
Hepatic Stellate Cells
53%
Hepatitis C
46%
Liver Diseases
39%
Liver Cirrhosis
33%
HIV
30%
Ribavirin
28%
Therapeutics
28%
Chronic Hepatitis C
27%
Neoplasms
26%
Liver Neoplasms
20%
Non-alcoholic Fatty Liver Disease
20%
Antiviral Agents
19%
Sorafenib
18%
Virus Diseases
18%
Interferons
18%
Fatty Liver
18%
Survival
16%
Transplant Recipients
16%
Wounds and Injuries
16%
Biliary Liver Cirrhosis
16%
Transplants
15%
Hepatitis B
15%
Hepatitis B virus
14%
Hepatocytes
14%
Genotype
14%
Hepatitis
13%
Autoimmune Hepatitis
13%
Genes
12%
Biopsy
12%
Biomarkers
12%
Transplantation
12%
Chronic Hepatitis B
12%
Sustained Virologic Response
11%
Allografts
11%
Sofosbuvir
11%
Chronic Disease
11%
Portal Hypertension
11%
Coinfection
11%
Tissue Donors
10%
Alcoholic Hepatitis
10%
Recurrence
10%
Infections
9%
Chemical and Drug Induced Liver Injury
9%
Mortality
9%
Placebos
9%
Safety
9%
RNA
9%
Collagen
9%
Kruppel-Like Factor 6
8%
Mutation
8%
peginterferon alfa-2a
8%
Alcohols
8%
Acute Liver Failure
8%
Transforming Growth Factors
8%
Clinical Trials
7%
Living Donors
7%
Inflammation
7%
Pharmaceutical Preparations
7%
Cholangiocarcinoma
7%
Extracellular Matrix
7%
Proteins
7%
ramucirumab
7%
Serum
7%
Apoptosis
7%
Sclerosing Cholangitis
7%
End Stage Liver Disease
6%
Population
6%
telaprevir
6%
Gene Expression
6%
sofosbuvir drug combination ledipasvir
6%
Incidence
6%
HIV Infections
6%
Cell Line
6%
Autophagy
6%
Coronavirus
6%
Ascites
5%
Myofibroblasts
5%
Graft Survival
5%
alpha-Fetoproteins
5%
Confidence Intervals
5%
Gastroenterology
5%
Epigenomics
5%
Discoidin Domain Receptor 2
5%
Transcriptional Activation
5%
Transcriptome
5%
Tenofovir
5%
Messenger RNA
5%